01.02.19
US Patent No. 10,123,970 B2; Sun Pharmaceutical Industries Limited, Mumbai, India, has received a US patent for a stable topical composition in the form of an unencapsulated single phase solution.
The topical composition consisting of a therapeutically effective amount of isotretinoin or its pharmaceutically acceptable salts; a pharmaceutically acceptable vehicle selected from the group consisting of one or more of fatty acid esters, or fatty acids, or vegetable oils in which the therapeutically effective amount of isotretinoin is soluble; and one or more pharmaceutically acceptable excipients. The composition is free of ethyl alcohol.
The topical composition consisting of a therapeutically effective amount of isotretinoin or its pharmaceutically acceptable salts; a pharmaceutically acceptable vehicle selected from the group consisting of one or more of fatty acid esters, or fatty acids, or vegetable oils in which the therapeutically effective amount of isotretinoin is soluble; and one or more pharmaceutically acceptable excipients. The composition is free of ethyl alcohol.
